Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Overview of progress in the epidemiology of age-related macular degeneration.

Klein R.

Ophthalmic Epidemiol. 2007 Jul-Aug;14(4):184-7. Review.

PMID:
17896295
2.

Risk factors for incident age-related macular degeneration: pooled findings from 3 continents.

Tomany SC, Wang JJ, Van Leeuwen R, Klein R, Mitchell P, Vingerling JR, Klein BE, Smith W, De Jong PT.

Ophthalmology. 2004 Jul;111(7):1280-7.

PMID:
15234127
3.

The epidemiology of age-related macular degeneration.

Klein R, Peto T, Bird A, Vannewkirk MR.

Am J Ophthalmol. 2004 Mar;137(3):486-95. Review.

PMID:
15013873
4.

Risk factors for age-related macular degeneration: Pooled findings from three continents.

Smith W, Assink J, Klein R, Mitchell P, Klaver CC, Klein BE, Hofman A, Jensen S, Wang JJ, de Jong PT.

Ophthalmology. 2001 Apr;108(4):697-704.

PMID:
11297486
5.

Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study.

Klein R, Klein BE, Knudtson MD, Meuer SM, Swift M, Gangnon RE.

Ophthalmology. 2007 Feb;114(2):253-62.

PMID:
17270675
6.

Prevalence and risk factors for age-related macular degeneration in an adult Japanese population: the Funagata study.

Kawasaki R, Wang JJ, Ji GJ, Taylor B, Oizumi T, Daimon M, Kato T, Kawata S, Kayama T, Tano Y, Mitchell P, Yamashita H, Wong TY.

Ophthalmology. 2008 Aug;115(8):1376-81, 1381.e1-2. doi: 10.1016/j.ophtha.2007.11.015.

PMID:
18222000
7.

The potential effect of population development, smoking and antioxidant supplementation on the future epidemiology of age-related macular degeneration in Switzerland.

Bauer P, Barthelmes D, Kurz M, Fleischhauer JC, Sutter FK.

Klin Monbl Augenheilkd. 2008 May;225(5):376-9. doi: 10.1055/s-2008-1027264.

PMID:
18454376
8.

Annual rates of arterial thromboembolic events in medicare neovascular age-related macular degeneration patients.

Alexander SL, Linde-Zwirble WT, Werther W, Depperschmidt EE, Wilson LJ, Palanki R, Saroj N, Butterworth SL, Ianchulev T.

Ophthalmology. 2007 Dec;114(12):2174-8.

PMID:
18054636
9.

Nine-year incidence and risk factors for age-related macular degeneration in a defined Japanese population the Hisayama study.

Yasuda M, Kiyohara Y, Hata Y, Arakawa S, Yonemoto K, Doi Y, Iida M, Ishibashi T.

Ophthalmology. 2009 Nov;116(11):2135-40. doi: 10.1016/j.ophtha.2009.04.017.

PMID:
19744734
10.

The epidemiology of age-related macular degeneration in the Indian subcontinent.

Woo JH, Sanjay S, Au Eong KG.

Acta Ophthalmol. 2009 May;87(3):262-9. doi: 10.1111/j.1755-3768.2008.01376.x. Review.

11.

Gender, oestrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study.

Smith W, Mitchell P, Wang JJ.

Aust N Z J Ophthalmol. 1997 May;25 Suppl 1:S13-5.

PMID:
9267614
12.

Prevalence and associated risk factors of age-related macular degeneration in an elderly Chinese population in Taiwan: the Shihpai Eye Study.

Chen SJ, Cheng CY, Peng KL, Li AF, Hsu WM, Liu JH, Chou P.

Invest Ophthalmol Vis Sci. 2008 Jul;49(7):3126-33. doi: 10.1167/iovs.08-1803.

PMID:
18390643
13.

A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration.

Karnon J, Czoski-Murray C, Smith K, Brand C, Chakravarthy U, Davis S, Bansback N, Beverley C, Bird A, Harding S, Chisholm I, Yang YC.

Health Technol Assess. 2008 Jun;12(27):iii-iv, ix-124.

14.

Prevalence of age-related macular degeneration in a Malay population: the Singapore Malay Eye Study.

Kawasaki R, Wang JJ, Aung T, Tan DT, Mitchell P, Sandar M, Saw SM, Wong TY; Singapore Malay Eye Study Group..

Ophthalmology. 2008 Oct;115(10):1735-41. doi: 10.1016/j.ophtha.2008.02.012.

PMID:
18439679
15.

Risk factors for second eye progression to advanced age-related macular degeneration: SST report No. 21 Submacular Surgery Trials Research Group.

Submacular Surgery Trials Research Group., Solomon SD, Jefferys JL, Hawkins BS, Bressler NM, Bressler SB.

Retina. 2009 Sep;29(8):1080-90. doi: 10.1097/IAE.0b013e3181b1baeb.

PMID:
19734762
16.

Incidence of exudative age-related macular degeneration among elderly Americans.

Javitt JC, Zhou Z, Maguire MG, Fine SL, Willke RJ.

Ophthalmology. 2003 Aug;110(8):1534-9.

PMID:
12917168
18.

[Neovascular age-related macular degeneration in Germany. Encroachment on the quality of life and the financial implications].

Pauleikhoff D, Scheider A, Wiedmann P, Gelisken F, Scholl HP, Roider I, Mohr A, Zlateva G, Xu X.

Ophthalmologe. 2009 Mar;106(3):242-51. doi: 10.1007/s00347-008-1797-9. German.

PMID:
18709375
19.

Association between circulating white blood cell count and long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study.

Shankar A, Mitchell P, Rochtchina E, Tan J, Wang JJ.

Am J Epidemiol. 2007 Feb 15;165(4):375-82.

PMID:
17110636
20.

Polymorphisms in the vascular endothelial growth factor gene and risk of age-related macular degeneration: the Rotterdam Study.

Boekhoorn SS, Isaacs A, Uitterlinden AG, van Duijn CM, Hofman A, de Jong PT, Vingerling JR.

Ophthalmology. 2008 Nov;115(11):1899-903. doi: 10.1016/j.ophtha.2008.06.026.

PMID:
18708255
Items per page

Supplemental Content

Support Center